Nuvaira, Inc. (formerly Holaira) is a medical device company headquartered in Maple Grove, Minnesota, that develops innovative therapies for patients with chronic respiratory conditions.
Subscribe to see NUVAIRA, INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
NUVAIRA, INC. is a surgical company headquartered in United States, founded in 2008. Its most recent funding round raised $35.8M in February 2026. Xcout tracks 19 named people at NUVAIRA, INC., including Dennis W. Wahr (Chief Executive Officer).
13 more named people on record for NUVAIRA, INC., with roles, board committees and tenure — see the full roster →
The 6 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $35.8M | — | |
| SEC Form D filing | $979,184 | — | |
| SEC Form D filing | $52,875 | — | |
| SEC Form D filing | $15.1M | — | |
| Undisclosed stage | $15.1M | — | |
| SEC Form D filing | $17.4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of NUVAIRA, INC.'s closest competitors — see the full list of competitors and alternatives →
Spirosure, Inc. is a U.S. medical-device company that develops breath-based diagnostic technology, particularly systems for measuring exhaled nitric oxide (FeNO). Its products are intended to help clinicians assess and manage airway inflammation in patients with asthma and related respiratory conditions.
Aevice Health develops non-invasive wearable medical devices for the continuous remote monitoring and auscultation of chronic respiratory diseases. The company provides tools that enable clinicians to track patient conditions and deliver seamless respiratory care.
Novaerus Group Ltd manufactures portable air disinfection devices and recirculating air cleaning systems powered by NanoStrike technology for continuous 24/7 protection. Their medical-grade and FDA-cleared products help inactivate airborne viruses, bacteria, mold spores, and pollen in environments such as healthcare facilities, commercial buildings, and educational institutions.
Createrna, Inc. is an innovative biopharmaceutical company dedicated to the discovery and development of treatments for immunology, respiratory, and cardiovascular diseases. The company focuses its research pipeline on addressing complex chronic conditions through targeted therapeutic approaches. Their portfolio highlights early-stage pharmaceutical developments in specialized medical fields.
QTREX Quantum Ltd. is an Israel-based specialized medical device firm. Its core activities encompass the research, development, manufacturing, and commercialization of unique life support technologies aimed at treating acute respiratory failure. The company provides the INSPIRA ART100, a vital life support system designed for cardiopulmonary bypass procedures lasting up to six hours. Additionally, it offers the HYLA blood sensor, engineered to deliver real-time sampling and analysis of critical blood parameter measurements. Founded in 2018, the company previously operated as Inspira Technologies Oxy B.H.N. Ltd. before rebranding to QTREX Quantum Ltd. in May 2026. Its primary operations are headquartered in Ra'anana, Israel.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.